IL102574A - Anantiospecific courtship of proxiral oxazolyl quion - Google Patents
Anantiospecific courtship of proxiral oxazolyl quionInfo
- Publication number
- IL102574A IL102574A IL10257492A IL10257492A IL102574A IL 102574 A IL102574 A IL 102574A IL 10257492 A IL10257492 A IL 10257492A IL 10257492 A IL10257492 A IL 10257492A IL 102574 A IL102574 A IL 102574A
- Authority
- IL
- Israel
- Prior art keywords
- process according
- borane
- methyl
- formula
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73356491A | 1991-07-22 | 1991-07-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL102574A0 IL102574A0 (en) | 1993-01-14 |
IL102574A true IL102574A (en) | 1996-07-23 |
Family
ID=24948157
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10257492A IL102574A (en) | 1991-07-22 | 1992-07-21 | Anantiospecific courtship of proxiral oxazolyl quion |
Country Status (21)
Country | Link |
---|---|
US (1) | US5512689A (fr) |
EP (1) | EP0595868B1 (fr) |
JP (1) | JP2671962B2 (fr) |
AT (1) | ATE173728T1 (fr) |
AU (1) | AU660701B2 (fr) |
CA (1) | CA2111445C (fr) |
DE (1) | DE69227689T2 (fr) |
DK (1) | DK0595868T3 (fr) |
ES (1) | ES2123562T3 (fr) |
FI (1) | FI940306A (fr) |
HU (1) | HUT70412A (fr) |
IE (1) | IE922359A1 (fr) |
IL (1) | IL102574A (fr) |
MX (1) | MX9204278A (fr) |
MY (1) | MY131277A (fr) |
NO (1) | NO940227D0 (fr) |
NZ (1) | NZ243651A (fr) |
PT (1) | PT100710B (fr) |
TW (1) | TW199891B (fr) |
WO (1) | WO1993002060A1 (fr) |
ZA (1) | ZA925469B (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5576442A (en) * | 1991-07-22 | 1996-11-19 | Pfizer Inc. | Process and chiral intermediates for thiazole antidiabetics |
FR2699172B1 (fr) * | 1992-12-11 | 1995-01-20 | Adir | Nouveaux dérivés de 4-méthyl-1,3-oxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
TW416958B (en) * | 1993-05-14 | 2001-01-01 | Pfizer | Enantioselective oxazaborolidine catalysts |
JP2003531104A (ja) * | 1999-08-31 | 2003-10-21 | マキシア・ファーマシューティカルズ・インコーポレイテッド | ベンジリデン−チアゾリジンジオン類およびアナログ類ならびに炎症の治療におけるその使用 |
BR0207846A (pt) | 2001-03-07 | 2005-09-13 | Incyte San Diego Inc | Derivados heterocìclicos para o tratamento de câncer e outras doenças proliferativas |
US7265139B2 (en) * | 2001-03-08 | 2007-09-04 | Incyte San Diego Inc. | RXR activating molecules |
CA2340824A1 (fr) * | 2001-03-14 | 2002-09-14 | Ibm Canada Limited-Ibm Canada Limitee | Methode et systeme pour l'analyse du comportement des applications |
JP2005500379A (ja) * | 2001-08-17 | 2005-01-06 | インサイト サンディエゴ インコーポレーテッド | 異脂肪血症および高コレステロール血症を治療するオキシム誘導体 |
WO2003043998A1 (fr) * | 2001-11-15 | 2003-05-30 | Incyte San Diego Incorporated | Heterocycles n-substitues pour le traitement de l'hypercholesterolemie, de la dyslipidemie et autres troubles du metabolisme, du cancer et de pathologies diverses |
US7102000B2 (en) * | 2002-03-08 | 2006-09-05 | Incyte San Diego Inc. | Heterocyclic amide derivatives for the treatment of diabetes and other diseases |
US7196108B2 (en) * | 2002-03-08 | 2007-03-27 | Incyte San Diego Inc. | Bicyclic heterocycles for the treatment of diabetes and other diseases |
US20050014767A1 (en) * | 2003-01-29 | 2005-01-20 | Magnus Pfahl | Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases |
JP2006523724A (ja) * | 2003-04-18 | 2006-10-19 | インサイト サン ディエゴ インコーポレイテッド | 代謝障害、癌および他の疾患の治療のための置換イソクロマン化合物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4943635A (en) * | 1987-08-27 | 1990-07-24 | President & Fellows Of Harvard College | Enantioselective reduction of ketones |
US5036079A (en) * | 1989-12-07 | 1991-07-30 | Pfizer Inc. | Hypoglycemic thiazolidinedione derivatives |
TW222626B (fr) * | 1991-07-22 | 1994-04-21 | Pfizer |
-
1992
- 1992-07-01 AU AU23062/92A patent/AU660701B2/en not_active Ceased
- 1992-07-01 EP EP92915192A patent/EP0595868B1/fr not_active Expired - Lifetime
- 1992-07-01 HU HU9400188A patent/HUT70412A/hu unknown
- 1992-07-01 CA CA002111445A patent/CA2111445C/fr not_active Expired - Fee Related
- 1992-07-01 DE DE69227689T patent/DE69227689T2/de not_active Expired - Fee Related
- 1992-07-01 ES ES92915192T patent/ES2123562T3/es not_active Expired - Lifetime
- 1992-07-01 WO PCT/US1992/005433 patent/WO1993002060A1/fr active IP Right Grant
- 1992-07-01 AT AT92915192T patent/ATE173728T1/de not_active IP Right Cessation
- 1992-07-01 DK DK92915192T patent/DK0595868T3/da active
- 1992-07-01 JP JP5502810A patent/JP2671962B2/ja not_active Expired - Fee Related
- 1992-07-07 TW TW081105396A patent/TW199891B/zh active
- 1992-07-20 PT PT100710A patent/PT100710B/pt not_active IP Right Cessation
- 1992-07-21 NZ NZ243651A patent/NZ243651A/en unknown
- 1992-07-21 ZA ZA925469A patent/ZA925469B/xx unknown
- 1992-07-21 IL IL10257492A patent/IL102574A/en not_active IP Right Cessation
- 1992-07-21 IE IE235992A patent/IE922359A1/en not_active IP Right Cessation
- 1992-07-21 MY MYPI92001294A patent/MY131277A/en unknown
- 1992-07-21 MX MX9204278A patent/MX9204278A/es unknown
-
1994
- 1994-01-21 NO NO940227A patent/NO940227D0/no unknown
- 1994-01-21 FI FI940306A patent/FI940306A/fi unknown
-
1995
- 1995-04-05 US US08/417,502 patent/US5512689A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
IE922359A1 (en) | 1993-01-27 |
ES2123562T3 (es) | 1999-01-16 |
TW199891B (fr) | 1993-02-11 |
DE69227689T2 (de) | 1999-04-22 |
ZA925469B (en) | 1994-01-21 |
PT100710B (pt) | 1999-07-30 |
EP0595868B1 (fr) | 1998-11-25 |
CA2111445A1 (fr) | 1993-02-04 |
CA2111445C (fr) | 1997-02-18 |
MY131277A (en) | 2007-07-31 |
NO940227L (no) | 1994-01-21 |
HU9400188D0 (en) | 1994-05-30 |
ATE173728T1 (de) | 1998-12-15 |
JP2671962B2 (ja) | 1997-11-05 |
DK0595868T3 (da) | 1999-08-09 |
JPH07502017A (ja) | 1995-03-02 |
FI940306A0 (fi) | 1994-01-21 |
HUT70412A (en) | 1995-10-30 |
MX9204278A (es) | 1994-03-31 |
NZ243651A (en) | 1994-01-26 |
FI940306A (fi) | 1994-01-21 |
PT100710A (pt) | 1993-09-30 |
US5512689A (en) | 1996-04-30 |
WO1993002060A1 (fr) | 1993-02-04 |
AU2306292A (en) | 1993-02-23 |
EP0595868A1 (fr) | 1994-05-11 |
NO940227D0 (no) | 1994-01-21 |
IL102574A0 (en) | 1993-01-14 |
DE69227689D1 (de) | 1999-01-07 |
AU660701B2 (en) | 1995-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU660701B2 (en) | Process for the preparation of intermediates in the synthesis of chiral thiazolidine-2,4-dione derivatives | |
AP776A (en) | Benzoxazoles and pyridine derivatives useful in the treatment of the type Ii diabetes. | |
CA1124245A (fr) | Composes du type acide interphenylene-9-thia-11-oxo-12-azaprostanoiques | |
WO1995017394A1 (fr) | Derives heterocycliques et leur utilisation dans des produits pharmaceutiques | |
CA2299447C (fr) | Procede permettant d'obtenir des enantiomeres de cis-olirtine | |
EP0640089B1 (fr) | Catalyseurs a oxazaborolidine enantioselectifs | |
JP3484200B2 (ja) | チアゾリジンジオンの改良製造方法及び新規なチアゾリジンジオン | |
LU86392A1 (fr) | Intermediaires intervenant dans la production d'epipodophyllotoxine et composes apparentes:procedes de preparation et emploi | |
RU2150472C1 (ru) | Способ получения диизопинокамфеилхлорборана в реакционной смеси, способ восстановления прохирального кетона | |
JP2546559B2 (ja) | ジイソピノカンフェイルクロロボランのインシトゥー製造 | |
ARAI et al. | Stereoselective reduction of chiral 3-(p-tolylsulfinyl)-2-thienyl ketones. A facile entry to optically active thienylcarbinols | |
JP2672029B2 (ja) | チアゾール系抗糖尿病薬製造用のキラル中間体 | |
US4243817A (en) | Prostenoic acids and esters | |
JPH04352745A (ja) | 光学活性アルコールの製法 | |
CA2085716A1 (fr) | Carbamates a substituant heterocyclique et methode pour les preparer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
RH | Patent void |